|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
1
|
Resverlogix Corp.
|
May 03, 2021 07:11AM
|
|
Re: Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
2
|
Resverlogix Corp.
|
May 02, 2021 09:44PM
|
|
Re: Still no trial.....wow
|
4
|
Resverlogix Corp.
|
Apr 30, 2021 07:09AM
|
|
Re: One more Exempt Distribution - 2021-04-26
|
3
|
Resverlogix Corp.
|
Apr 28, 2021 09:54AM
|
|
Re: Management performance
|
5
|
Resverlogix Corp.
|
Apr 27, 2021 12:11PM
|
|
Re: Update on Bioasis
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 27, 2021 12:06PM
|
|
Re: How many other "Alex Kopacz's" are out there...as we wait our turn on the tarmac?
|
3
|
Resverlogix Corp.
|
Apr 27, 2021 07:41AM
|
|
Re: Study readouts this week or next?
|
|
BIOASIS TECHNOLOGIES INC
|
Apr 27, 2021 07:12AM
|
|
Re: Parallel Universe ?
|
4
|
Resverlogix Corp.
|
Apr 23, 2021 08:50PM
|
|
Re: ZEN-3694 and Enzalutamide 2b Trial
|
3
|
Zenith Epigenetics
|
Apr 23, 2021 08:34PM
|
|
Re: Level ll on the sell side.
|
5
|
Resverlogix Corp.
|
Apr 19, 2021 04:16PM
|
|
Level ll on the sell side.
|
3
|
Resverlogix Corp.
|
Apr 19, 2021 03:31PM
|
|
Re: Another Exempt Distribution - 2021-04-15
|
3
|
Resverlogix Corp.
|
Apr 17, 2021 01:46PM
|
|
Re: Another Exempt Distribution - 2021-04-15
|
4
|
Resverlogix Corp.
|
Apr 17, 2021 12:08PM
|
|
Re: Exempt Dist.
|
3
|
Zenith Epigenetics
|
Apr 16, 2021 05:41PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
7
|
Resverlogix Corp.
|
Apr 15, 2021 06:33AM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
4
|
Resverlogix Corp.
|
Apr 14, 2021 12:01PM
|
|
Re: Give us just one or two NR’s - money, partners & timeframe
|
4
|
Resverlogix Corp.
|
Apr 13, 2021 05:25PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
3
|
Resverlogix Corp.
|
Apr 12, 2021 07:13PM
|
|
Re: Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19
|
5
|
Resverlogix Corp.
|
Apr 12, 2021 06:48PM
|
